Polyhexanide

 ( Antiseptics And Disinfectants ) 

Polyhexanide ( polyhexamethylene biguanide, PHMB) is a polymer used as a disinfectant and antiseptic. In dermatological use, it is spelled polihexanide (INN) and sold under various brand names.: Polihexanide PHMB has been shown to be effective against Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Candida albicans, Aspergillus brasiliensis, enterococci, and Klebsiella pneumoniae.Maribeth Cousin, Kimberly Restivo, Chelsea Rodriguez, and Justin Lien. USP Antimicrobial Effectiveness Test (GLP). Elkhorn, WI: Geneva Laboratories. 2013. Polihexanide, sold under the brand name Akantior is a medication used for the treatment of Acanthamoeba keratitis.

Products containing PHMB are used for inter-operative irrigation, pre- and post-surgery skin and mucous membrane disinfection, post-operative dressings, surgical and non-surgical wound dressings, surgical bath/hydrotherapy, chronic wounds like diabetic foot ulcer and burn wound management, routine antisepsis during minor incisions, Catheter, first aid, surface disinfection, and linen disinfection. PHMB eye drops have been used as a treatment for eyes affected by Acanthamoeba keratitis.

It is sold as a swimming pool and spa disinfectant in place of chlorine or bromine based products under the name Baquacil.

PHMB is also used as an ingredient in some contact lens cleaning products, cosmetics, personal deodorants and some veterinary products. It is also used to treat clothing (Purista), purportedly to prevent the development of unpleasant odors.

The PHMB hydrochloride salt (solution) is used in the majority of formulations.

---

Use in Acanthamoeba keratitis treatment Polihexanide is indicated for the treatment of Acanthamoeba keratitis in people aged 12 years of age and older.

---

Legal status

In May 2024, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Akantior, intended for the treatment of Acanthamoeba keratitis, a severe, progressive and sight threatening corneal infection characterized by intense pain and photophobia. Acanthamoeba keratitis is a rare disease primarily affecting contact lens wearers. The applicant for this medicinal product is SIFI SPA. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. Polihexanide was approved for medical use in the European Union in August 2024.

---

Safety

In 2011, polyhexamethylene biguanide was classified as category 2 carcinogen by the European Chemical Agency, but it is still allowed in cosmetics in small quantities if exposure by inhalation is impossible.

---

Name controversy

In some sources, particularly when listed as a cosmetics ingredient (INCI), the polymer is wrongly named as polyaminopropyl biguanide.

Categories: Antiseptics And Disinfectants, Biguanides, Polymers

Post Comment